BFSG »

Xeris Pharmaceuticals shares owned by BFSG

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by BFSG

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.7k 2.0k 2.85
2024-06-30 $4.5k 2.0k 2.25
2024-03-31 $4.4k 2.0k 2.21
2023-12-31 $4.7k 2.0k 2.35

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Church & Dwight (CHD)
Raytheon Technologies Corp (RTX)
Vanguard World Energy Etf (VDE)
CSX Corporation (CSX)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Novo-nordisk A S Adr (NVO)

View all positions for BFSG

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals